27.11.2012 Views

clinical - Nobel Biocare

clinical - Nobel Biocare

clinical - Nobel Biocare

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

All-on-Four Immediate Function Treatment<br />

Two patients aged 70 and 68 years were<br />

lost to follow-up at the 1-year and less than<br />

3-month visit. These patients passed away<br />

due to natural causes. Two additional<br />

patients were lost to follow-up at the 3month<br />

follow-up visit. Therefore, a total of 16<br />

implants have been lost to follow-up. One<br />

hundred sixty-two patients in the study have<br />

completed the 6-month follow-up and have<br />

had their definitive prostheses (174) delivered.<br />

Three jaws were lost to follow-up prior<br />

to definitive prosthetic delivery, and 1 jaw<br />

was lost to follow-up after definitive prosthetic<br />

delivery. One hundred fifty-six patients<br />

have completed the 1-year follow-up.<br />

The overall implant survival rate was<br />

99.6% (1 year; Table 4) with no significant<br />

TABLE 3<br />

Implant size (<strong>Nobel</strong>Active TiUnite)*<br />

Implant Diameter Implant Length, mm Maxillae Mandibles<br />

3.5 8.5 — —<br />

10 — —<br />

11.5 12 —<br />

13 31 9<br />

15 28 (1) 42<br />

4.3 8.5 — —<br />

10 2 2<br />

11.5 16 7<br />

13 84 18<br />

15 94 92<br />

18 4 1<br />

5.0 8.5 — —<br />

10 — —<br />

11.5 5 1<br />

13 20 15<br />

15 131 (2) 81<br />

18 9 4<br />

436 (3) 272<br />

*( ) indicates failed implants/replaced.<br />

TABLE 4<br />

Cumulative survival analysis*<br />

Placed/Followed<br />

Implants<br />

difference between the maxillae and mandibles<br />

(99.3% vs 100%, P 5 .06, Fisher exact<br />

test). The 4.3-mm-diameter implants were<br />

most frequently used, with a survival rate of<br />

100% (99.2% for 3.5 mm and 99.2% for<br />

5.0 mm; Figure 1). No total arch failures have<br />

occurred to date, providing a definitive<br />

prosthesis survival rate of 100%. The life<br />

table analysis demonstrating the cumulative<br />

survival rate is reported in Table 4.<br />

Figures 2 through 8 demonstrate a case in<br />

postextraction sites of the mandible and<br />

maxilla with immediate implant placement,<br />

Figures 9 through 14 show a case in healed<br />

sites of a patient with a severely atrophic<br />

edentulous maxilla. The patient has been<br />

edentulous for 50 years. Figures 15 through<br />

Failed<br />

Implants<br />

Time Not<br />

Passed<br />

Lost to<br />

Follow-up CSR<br />

Implant insertion »» 3 months 708 1 0 4 99.9<br />

3 months »» 6 months 703 1 0 8 99.7<br />

6 months »» 12 months 694 1 29 0 99.6<br />

12 months »» 18 months 664 0 336 4 99.6<br />

18 months »» 24 months 324 0 240 0 99.6<br />

»» 24 months 84 0<br />

*CSR indicates cumulative survival rate.<br />

436 Vol. XXXVII/No. Four/2011

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!